The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
Lifelong Mental Stimulation Linked to Significant Delay in Alzheimer’s Disease Onset and Slower Cognitive Decline
Engaging in a consistent regimen of mentally stimulating activities throughout one’s life, such as reading, writing, and the acquisition of…
Read More
Sanofi Receives FDA Approval to Expand Tzield Use in Children as Young as One Year for Type 1 Diabetes Delay
Sanofi has secured a significant expansion of its U.S. Food and Drug Administration (FDA) approval for Tzield (teplizumab-mzwv), a groundbreaking…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Onset and Slower Mental Decline
A comprehensive study published in the medical journal of the American Academy of Neurology, Neurology, has revealed a profound correlation…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive Decline
Engaging in mentally stimulating activities across a person’s entire lifespan—ranging from childhood reading habits to learning new languages and playing…
Read More
